Autoantibodies against IL-1α were detected in the sera of 11/11 rapidly progressive IPF patients on the 21st hospital day following admission for severe symptoms (compared to 5/11 on the first hospital day) suggesting that extracellular IL-1α may be an undesirable factor in fibrotic lung diseases [94]. This evidence concerns the gene IL1A and idiopathic pulmonary fibrosis.